Dyax Corp. Announces Extension of Antibody Library Collaboration with ImClone Systems Incorporated

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today the extension of the antibody library collaboration with ImClone Systems Incorporated (NASDAQ: IMCL) for the discovery of therapeutic antibodies. Under the terms of this agreement, ImClone will continue to have access to Dyax’s proprietary phage display technology for an additional four years.

MORE ON THIS TOPIC